All of the sub-projects rely on the availability of high quality and high purity human cardiomyocytes that have been derived from patient-specific induced pluripotent stem cells (iPSCs).The overall objective of the Stem Cell Core is to provide the infrastructure, materials, and expertise to support the maintenance, derivation and differentiation of human pluripotent stem cells for PPG investigators. Although primary human cardiomyocytes could ostensibly be collected from patients, the logistics involved in harvesting cells from both control and type 2 diabetic populations make this approach infeasible. In addition, primary cardiac cells have a limited lifespan and cannot be expanded to provide the cell numbers necessary to meet the goals of the PPG. In contrast, human iPSCs can act as an indefatigable reservoir of human cardiomyocytes that can be cultured for over one year.
The specific aims of the Stem Cell Core are therefore to: (1) Reprogram new iPSC lines from non-diabetic and type 2 diabetic patients; (2) Generate reagents under strict quality control that are necessary for iPSC culture; (3) Provide training in the culture, handling, and differentiation of human iPSCs as required by PPG investigators; and (4) Supply purified iPSC-derived cardiomyocytes expressing enhanced green fluorescent protein to PPG investigators.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Medical College of Wisconsin
United States
Zip Code
Pant, Tarun; Dhanasekaran, Anuradha; Fang, Juan et al. (2018) Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord 18:197
Ge, Zhi-Dong; Li, Yingchuan; Qiao, Shigang et al. (2018) Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I. Anesthesiology 128:117-129
Williams, Anna Marie; Liu, Yong; Regner, Kevin R et al. (2018) Artificial intelligence, physiological genomics, and precision medicine. Physiol Genomics 50:237-243
Liu, Pengyuan; Liu, Yong; Liu, Han et al. (2018) Role of DNA De Novo (De)Methylation in the Kidney in Salt-Induced Hypertension. Hypertension 72:1160-1171
Chuppa, Sandra; Liang, Mingyu; Liu, Pengyuan et al. (2018) MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4. Kidney Int 93:375-389
Korman, Ben; Dash, Ranjan K; Peyton, Philip J (2018) Can Mathematical Modeling Explain the Measured Magnitude of the Second Gas Effect? Anesthesiology 128:1075-1083
Liu, Yong; Usa, Kristie; Wang, Feng et al. (2018) MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension. J Am Soc Nephrol 29:2518-2528
Zhang, Xiao; Dash, Ranjan K; Jacobs, Elizabeth R et al. (2018) Integrated computational model of the bioenergetics of isolated lung mitochondria. PLoS One 13:e0197921
Ghanian, Zahra; Konduri, Girija Ganesh; Audi, Said Halim et al. (2018) Quantitative optical measurement of mitochondrial superoxide dynamics in pulmonary artery endothelial cells. J Innov Opt Health Sci 11:
Liang, Mingyu (2018) Epigenetic Mechanisms and Hypertension. Hypertension 72:1244-1254

Showing the most recent 10 out of 134 publications